RENAU.UNSP.ARD 1/5 EO-20 (56S0 F) stock market data APIs
€16.4923
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
RENAU.UNSP.ARD 1/5 EO-20 Financial Data Overview
Price chart is built with
Anychart
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Prev. Close
16.4923
Open
16.4923
High
16.4923
Low
16.4923
52 wk Range
14.7-22.1118
Market Cap
16 465 M
P/E Ratio
71.7391
Shares Outstanding
973 M
Revenue
2 896 M
Dividends (Yield)
0.0408
Beta
0.888
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get RENAU.UNSP.ARD 1/5 EO-20 data using free add-ons & libraries
Get RENAU.UNSP.ARD 1/5 EO-20 Fundamental Data
RENAU.UNSP.ARD 1/5 EO-20 Fundamental data includes:
- Net Revenue: 2 896 M
- EBITDA: 695 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
RENAU.UNSP.ARD 1/5 EO-20 News
New
European Hidden Value Stocks That Might Be Priced Below Intrinsic Estimates
Amidst concerns over the independence of the U.S. Federal Reserve and renewed tariff uncertainties, European markets have experienced a downturn, with major indices like the STOXX Europe 600 Index clo...
Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing
Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for NanoSpark® activation products Joint development of n...
3 European Stocks Estimated At Up To 41.3% Discount To Intrinsic Value
As European markets navigate the complexities of potential EU-U.S. trade deals and a slightly hawkish stance from the European Central Bank, investors are keenly observing opportunities that may arise...
Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa
Bio Usawa Inc KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius St...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
